Statin Function as an Anti-inflammation Therapy for Depression in Patients With Coronary Artery Disease by

Wenlin Ma1, Dan Shen, Jie Liu

  • 1*Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; †Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China; ‡Translational Center for Stem Cell Research, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; §Department of Clinical Laboratory, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; ¶Department of Psychiatry, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; and ‖Department of Stomatology, Huashan Hospital, Fudan University, Shanghai, China.

Insights

Inflammation is linked to coronary artery disease (CAD) and depression. Statins may treat depression in CAD patients by reducing inflammation, specifically by downregulating Interleukin-1 beta (IL-1β).

Area of Science:

  • Cardiology
  • Psychiatry
  • Immunology

Background:

  • Inflammation is a known contributor to both coronary artery disease (CAD) and depressive symptoms.
  • Previous research indicates statin therapy can reduce depression incidence in CAD patients, but the underlying mechanisms require elucidation.

Purpose of the Study:

  • To investigate the role of inflammation in depression among patients with CAD.
  • To explore the anti-inflammatory mechanism of statins in treating depression in this patient population.

Main Methods:

  • 217 hospitalized CAD patients were assessed for depression severity using the 9-item Patient Health Questionnaire.
  • Peripheral blood inflammatory markers, including IL-1β, were measured.
  • Luciferase reporter assays were used to assess IL-1β and NF-κB expression in response to patient serum and atorvastatin treatment.

Main Results:

  • Patients with severe depression and CAD exhibited significantly higher IL-1β levels compared to those with no or milder depression.
  • Serum from CAD patients with depression upregulated IL-1β and NF-κB expression.
  • Atorvastatin treatment reduced IL-1β and NF-κB reporter gene expression.

Conclusions:

  • Depression in CAD patients is associated with heightened inflammation.
  • Statins may exert their antidepressant effects in CAD patients through anti-inflammatory actions, specifically by downregulating IL-1β.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
583
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
673
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
467
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K